Compare NNNN & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNNN | CLMT |
|---|---|---|
| Founded | 2021 | 1916 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 2.1B |
| IPO Year | 2025 | 2006 |
| Metric | NNNN | CLMT |
|---|---|---|
| Price | $24.60 | $28.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $21.25 |
| AVG Volume (30 Days) | 88.1K | ★ 1.5M |
| Earning Date | 04-28-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | $6,920,153.00 | ★ $4,048,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.65 |
| P/E Ratio | $412.64 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.18 | $7.68 |
| 52 Week High | $55.65 | $29.20 |
| Indicator | NNNN | CLMT |
|---|---|---|
| Relative Strength Index (RSI) | 45.58 | 86.97 |
| Support Level | $21.09 | $24.97 |
| Resistance Level | $28.00 | $26.07 |
| Average True Range (ATR) | 6.58 | 1.13 |
| MACD | 0.16 | 0.43 |
| Stochastic Oscillator | 21.97 | 92.63 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.